Orthofix Medical Inc. Selling and Marketing Expense
Orthofix Medical Inc. (OFIX) reported Selling and Marketing Expense of $96.58 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2024-11-07
- Orthofix Medical Inc. selling and marketing expense for the quarter ending 2024-09-30 was $96.58M, a 1.72% increase year-over-year.
- Orthofix Medical Inc. selling and marketing expense for the quarter ending 2024-06-30 was $100.22M, a 0.98% increase year-over-year.
- Orthofix Medical Inc. selling and marketing expense for the quarter ending 2024-03-31 was $100.04M, a 6.67% increase year-over-year.
- Orthofix Medical Inc. selling and marketing expense for the quarter ending 2023-12-31 was $97.75M, a 64.77% increase year-over-year.
- Orthofix Medical Inc. selling and marketing expense for fiscal 2023 was $385.74M, a 68.58% increase from fiscal 2022.
- Orthofix Medical Inc. selling and marketing expense for fiscal 2022 was $228.81M, a 3.39% increase from fiscal 2021.
- Orthofix Medical Inc. selling and marketing expense for fiscal 2021 was $221.32M, a 8.26% increase from fiscal 2020.
- Orthofix Medical Inc. selling and marketing expense for fiscal 2020 was $204.43M, a 8.60% decline from fiscal 2019.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $96.58M 10-Q · filed 2024-11-07 | $196.80M derived: sum of 2 quarters · filed 2024-11-07 | $296.84M 10-Q · filed 2024-11-07 | $394.59M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2024-06-30 | $100.22M 10-Q · filed 2024-08-06 | $200.27M 10-Q · filed 2024-08-06 | $298.02M derived: sum of 3 quarters · filed 2024-08-06 | $392.96M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2024-03-31 | $100.04M 10-Q · filed 2024-05-07 | $197.79M derived: sum of 2 quarters · filed 2024-05-07 | $292.74M derived: sum of 3 quarters · filed 2024-11-07 | $391.99M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-12-31 | $97.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $192.70M derived: sum of 2 quarters · filed 2024-11-07 | $291.94M derived: sum of 3 quarters · filed 2024-11-07 | $385.74M 10-K · filed 2024-03-05 | ||||
| 2023-09-30 | $94.95M 10-Q · filed 2024-11-07 | $194.20M derived: sum of 2 quarters · filed 2024-11-07 | $287.99M 10-Q · filed 2024-11-07 | $347.31M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $99.25M 10-Q · filed 2024-08-06 | $193.04M 10-Q · filed 2024-08-06 | $252.36M derived: sum of 3 quarters · filed 2024-08-06 | $307.82M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $93.79M 10-Q · filed 2024-05-07 | $153.12M derived: sum of 2 quarters · filed 2024-05-07 | $208.58M derived: sum of 3 quarters · filed 2024-05-07 | $268.46M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $59.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $114.78M derived: sum of 2 quarters · filed 2024-03-05 | $174.67M derived: sum of 3 quarters · filed 2024-03-05 | $228.81M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $55.46M 10-Q · filed 2023-11-08 | $115.35M derived: sum of 2 quarters · filed 2023-11-08 | $169.49M 10-Q · filed 2023-11-08 | $226.58M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $59.89M 10-Q · filed 2023-08-08 | $114.03M 10-Q · filed 2023-08-08 | $171.12M derived: sum of 3 quarters · filed 2024-03-05 | $227.22M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | $54.14M 10-Q · filed 2023-05-09 | $111.23M derived: sum of 2 quarters · filed 2024-03-05 | $167.33M derived: sum of 3 quarters · filed 2024-03-05 | $224.67M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | $57.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $113.19M derived: sum of 2 quarters · filed 2024-03-05 | $170.53M derived: sum of 3 quarters · filed 2024-03-05 | $221.32M 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | $56.10M 10-Q · filed 2022-11-03 | $113.44M derived: sum of 2 quarters · filed 2022-11-03 | $164.22M 10-Q · filed 2022-11-03 | $217.94M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $57.34M 10-Q · filed 2022-08-05 | $108.12M 10-Q · filed 2022-08-05 | $161.84M derived: sum of 3 quarters · filed 2023-03-06 | $214.76M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | $50.78M 10-Q · filed 2022-05-06 | $104.50M derived: sum of 2 quarters · filed 2023-03-06 | $157.43M derived: sum of 3 quarters · filed 2023-03-06 | $200.91M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $53.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $106.64M derived: sum of 2 quarters · filed 2023-03-06 | $150.12M derived: sum of 3 quarters · filed 2023-03-06 | $204.43M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $52.93M 10-Q · filed 2021-11-05 | $96.41M derived: sum of 2 quarters · filed 2021-11-05 | $150.72M 10-Q · filed 2021-11-05 | $209.03M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $43.48M 10-Q · filed 2021-08-06 | $97.79M 10-Q · filed 2021-08-06 | $156.10M derived: sum of 3 quarters · filed 2022-02-25 | $210.91M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $54.31M 10-Q · filed 2021-04-30 | $112.63M derived: sum of 2 quarters · filed 2022-02-25 | $167.43M derived: sum of 3 quarters · filed 2022-02-25 | $224.29M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $58.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $113.12M derived: sum of 2 quarters · filed 2022-02-25 | $169.98M derived: sum of 3 quarters · filed 2022-02-25 | $223.68M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $54.80M 10-Q · filed 2020-11-05 | $111.67M derived: sum of 2 quarters · filed 2020-11-05 | $165.36M 10-Q · filed 2020-11-05 | $219.19M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $56.86M 10-Q · filed 2020-08-06 | $110.56M 10-Q · filed 2020-08-06 | $164.39M derived: sum of 3 quarters · filed 2021-02-26 | $214.29M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $53.69M 10-Q · filed 2020-05-08 | $107.53M derived: sum of 2 quarters · filed 2021-02-26 | $157.42M derived: sum of 3 quarters · filed 2021-02-26 | $208.95M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $53.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $103.73M derived: sum of 2 quarters · filed 2021-02-26 | $155.26M derived: sum of 3 quarters · filed 2021-02-26 | $205.53M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $49.90M 10-Q · filed 2019-10-28 | $101.43M derived: sum of 2 quarters · filed 2019-10-28 | $151.69M 10-Q · filed 2019-10-28 | $203.57M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $51.53M 10-Q · filed 2019-08-05 | $101.80M 10-Q · filed 2019-08-05 | $153.67M derived: sum of 3 quarters · filed 2020-02-24 | $201.16M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $50.27M 10-Q · filed 2019-05-06 | $102.14M derived: sum of 2 quarters · filed 2020-02-24 | $149.63M derived: sum of 3 quarters · filed 2020-02-24 | $200.11M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $51.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $99.37M derived: sum of 2 quarters · filed 2020-02-24 | $149.84M derived: sum of 3 quarters · filed 2020-02-24 | $198.37M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $47.49M 10-Q · filed 2018-10-29 | $97.96M derived: sum of 2 quarters · filed 2018-10-29 | $146.50M 10-Q · filed 2018-10-29 | $195.20M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $50.47M 10-Q · filed 2018-08-06 | $99.00M 10-Q · filed 2018-08-06 | $147.71M derived: sum of 3 quarters · filed 2019-02-25 | $189.43M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $48.53M 10-Q · filed 2018-04-30 | $97.24M derived: sum of 2 quarters · filed 2019-02-25 | $138.95M derived: sum of 3 quarters · filed 2019-02-25 | $185.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $48.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $90.42M derived: sum of 2 quarters · filed 2019-02-25 | $136.47M derived: sum of 3 quarters · filed 2019-02-25 | $181.29M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $41.72M 10-Q · filed 2017-10-30 | $87.76M derived: sum of 2 quarters · filed 2017-10-30 | $132.58M 10-Q · filed 2017-10-30 | $177.30M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $46.04M 10-Q · filed 2017-08-07 | $46.04M 10-Q · filed 2016-08-01 | $90.86M 10-Q · filed 2017-08-07 | $90.85M 10-Q · filed 2016-08-01 | $135.59M derived: sum of 3 quarters · filed 2018-02-26 | $181.71M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $44.82M 10-Q · filed 2017-05-04 | $44.82M 10-Q · filed 2016-04-28 | $89.54M derived: sum of 2 quarters · filed 2018-02-26 | $135.67M derived: sum of 3 quarters · filed 2018-02-26 | $178.62M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $44.72M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $90.85M derived: sum of 2 quarters · filed 2018-02-26 | $133.79M derived: sum of 3 quarters · filed 2018-02-26 | $178.08M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $46.13M 10-Q · filed 2016-10-31 | $89.08M derived: sum of 2 quarters · filed 2016-10-31 | $133.36M 10-Q · filed 2016-10-31 | $175.72M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $42.95M 10-Q · filed 2016-08-01 | $87.23M 10-Q · filed 2016-08-01 | $129.60M derived: sum of 3 quarters · filed 2017-02-27 | $170.59M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $44.28M 10-Q · filed 2016-04-28 | $86.65M derived: sum of 2 quarters · filed 2017-02-27 | $127.65M derived: sum of 3 quarters · filed 2017-02-27 | $169.66M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $42.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $83.36M derived: sum of 2 quarters · filed 2017-02-27 | $125.38M derived: sum of 3 quarters · filed 2017-02-27 | $166.55M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $41.00M 10-Q · filed 2015-11-03 | $83.01M derived: sum of 2 quarters · filed 2015-11-03 | $124.18M 10-Q · filed 2015-11-03 | $170.19M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $42.01M 10-Q · filed 2015-08-04 | $83.18M 10-Q · filed 2015-08-04 | $129.19M derived: sum of 3 quarters · filed 2016-02-29 | $168.27M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $41.17M 10-Q · filed 2015-05-18 | $43.87M 10-Q · filed 2014-05-08 | $87.18M derived: sum of 2 quarters · filed 2016-02-29 | $126.26M derived: sum of 3 quarters · filed 2016-02-29 | $170.79M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $46.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $85.08M derived: sum of 2 quarters · filed 2016-02-29 | $129.62M derived: sum of 3 quarters · filed 2016-02-29 | $175.47M 10-K · filed 2016-02-29 | $176.58M 10-K · filed 2014-03-31 | |||
| 2013-09-30 | $39.08M 10-Q · filed 2015-03-31 | $42.38M 10-Q · filed 2014-03-25 | $83.61M derived: sum of 2 quarters · filed 2015-03-31 | $129.46M 10-Q · filed 2015-03-31 | $132.35M 10-Q · filed 2014-03-25 | $171.00M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-06-30 | $44.54M 10-Q · filed 2015-03-31 | $44.91M 10-Q · filed 2014-03-24 | $90.38M 10-Q · filed 2015-03-31 | $89.96M 10-Q · filed 2014-03-24 | $131.93M derived: sum of 3 quarters · filed 2015-04-29 | $174.95M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-03-31 | $45.84M 10-Q/A · filed 2015-03-31 | $48.84M 10-Q · filed 2013-05-09 | $87.39M derived: sum of 2 quarters · filed 2015-04-29 | $130.41M derived: sum of 3 quarters · filed 2015-04-29 | $177.49M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2012-12-31 | $41.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29 | $84.57M derived: sum of 2 quarters · filed 2015-04-29 | $131.64M derived: sum of 3 quarters · filed 2015-04-29 | $178.77M 10-K · filed 2015-04-29 | $200.34M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $43.02M 10-Q · filed 2014-03-25 | $49.30M 10-Q · filed 2012-11-02 | $90.10M derived: sum of 2 quarters · filed 2014-03-25 | $137.22M 10-Q · filed 2014-03-25 | $148.63M 10-Q · filed 2012-11-02 | $175.62M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-06-30 | $47.08M 10-Q · filed 2014-03-24 | $49.81M 10-Q · filed 2012-07-30 | $94.20M 10-Q · filed 2014-03-24 | $99.33M 10-Q · filed 2012-07-30 | $132.60M derived: sum of 3 quarters · filed 2015-03-31 | $181.96M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-03-31 | $47.13M 10-Q/A · filed 2014-03-24 | $58.28M 10-Q · filed 2012-05-04 | $85.53M derived: sum of 2 quarters · filed 2015-03-31 | $134.88M derived: sum of 3 quarters · filed 2015-03-31 | $184.84M derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2011-12-31 | $38.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | $87.76M derived: sum of 2 quarters · filed 2015-03-31 | $137.72M derived: sum of 3 quarters · filed 2015-03-31 | $185.16M 10-K/A · filed 2015-03-31 | $233.61M 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $49.36M 10-Q · filed 2012-11-02 | $57.62M 10-Q · filed 2011-10-31 | $99.32M derived: sum of 2 quarters · filed 2012-11-02 | $146.76M 10-Q · filed 2012-11-02 | $171.41M 10-Q · filed 2011-10-31 | $180.27M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-06-30 | $49.96M 10-Q · filed 2012-07-30 | $58.20M 10-Q · filed 2011-08-05 | $97.40M 10-Q · filed 2012-07-30 | $113.80M 10-Q · filed 2011-08-05 | $130.91M derived: sum of 3 quarters · filed 2014-03-24 | $188.20M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-03-31 | $55.60M 10-Q · filed 2012-05-04 | $80.95M derived: sum of 2 quarters · filed 2014-03-24 | $138.24M derived: sum of 3 quarters · filed 2014-03-24 | $195.42M derived: sum of 4 quarters · filed 2014-03-24 | ||||
| 2010-12-31 | $25.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $82.64M derived: sum of 2 quarters · filed 2014-03-24 | $139.82M derived: sum of 3 quarters · filed 2014-03-24 | $196.11M 10-K/A · filed 2014-03-24 | $230.94M 10-K · filed 2012-02-29 | |||
| 2010-09-30 | $57.28M 10-Q · filed 2011-10-31 | $114.47M derived: sum of 2 quarters · filed 2011-10-31 | $170.76M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $57.19M 10-Q · filed 2011-08-05 | $113.47M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $215.94M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |